Danske Bank A/s »

Immunic shares owned by Danske Bank A/s

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Danske Bank A/s from 13F filings

Historical chart of Danske Bank A/s investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Danske Bank A/s consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Danske Bank A/s

Quarter filed Position value Share count Share price at filing
2026-06-30 $31 2 15.50

More positions owned by Danske Bank A/s

NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Berkshire Hathaway Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Danske Bank A/s

Top funds holding Immunic

Standard Life Aberdeen
BVF
Millennium Management
Avidity Partners Management
Braidwell
Laurion Capital Management
Vanguard Capital Management
Jones Hill Capital
Woodline Partners
Soleus Capital Management
Propel Bio Management
Susquehanna International
Nantahala Capital Management
UBS Group
Geode Capital Management

View all funds holding Immunic